Novartis Seems Close to Consumer Health Sale – Analyst
This article was originally published in The Tan Sheet
Executive Summary
Novartis CEO Joe Jimenez made clear the firm is considering divesting its consumer product, animal health and vaccines and diagnostics business, Sanford and Bernstein analysts say. “It seems that Novartis will be making final decisions with these units fairly soon,” they say.